Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen Delaney

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 30, 2012
HHV-6 reactivation and associated sequelae after hematopoietic cell transplantationDanielle M Zerr, Michael Boeckh, Colleen Delaney, et al.
Blood Advances|February 19, 2025
Long-term outcomes and quality of life with treosulfan-based conditioning in hematological malignanciesRohtesh S Mehta, Stephanie J Lee, Ted Gooley, et al.
Blood Advances|April 19, 2019
CD34<sup>+</sup> cell content of 126 341 cord blood units in the US inventory: implications for transplantation and bankingJuliet N Barker, Jane Kempenich, Joanne Kurtzberg, et al.
Blood Advances|August 17, 2021
Delayed-onset cytomegalovirus infection is frequent after discontinuing letermovir in cord blood transplant recipientsJoshua A Hill, Danniel Zamora, Hu Xie, et al.
Bone Marrow Transplantation|January 24, 2019
Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in childrenAnn Dahlberg, Wendy Leisenring, Marie Bleakley, et al.
Blood|March 11, 2011
HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipientsDanielle M Zerr, Jesse R Fann, David Breiger, et al.
Blood|July 28, 2011
Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cellsCameron J Turtle, Jeff Delrow, Rochelle C Joslyn, et al.
The Lancet. Haematology|July 5, 2016
Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trialColleen Delaney, Filippo Milano, Laura Cicconi, et al.
Journal of Holistic Nursing : Official Journal of the American Holistic Nurses' Association|January 3, 2018
Trends in Contemporary Holistic Nursing Research: 2010-2015Colleen Delaney, Ruth G McCaffrey, Cynthia Barrere, et al.
Blood Advances|July 25, 2020
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter studyFilippo Milano, Jonathan A Gutman, H Joachim Deeg, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 30, 2012
HHV-6 reactivation and associated sequelae after hematopoietic cell transplantationDanielle M Zerr, Michael Boeckh, Colleen Delaney, et al.
Blood Advances|February 19, 2025
Long-term outcomes and quality of life with treosulfan-based conditioning in hematological malignanciesRohtesh S Mehta, Stephanie J Lee, Ted Gooley, et al.
Blood Advances|April 19, 2019
CD34<sup>+</sup> cell content of 126 341 cord blood units in the US inventory: implications for transplantation and bankingJuliet N Barker, Jane Kempenich, Joanne Kurtzberg, et al.
Blood Advances|August 17, 2021
Delayed-onset cytomegalovirus infection is frequent after discontinuing letermovir in cord blood transplant recipientsJoshua A Hill, Danniel Zamora, Hu Xie, et al.
Bone Marrow Transplantation|January 24, 2019
Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in childrenAnn Dahlberg, Wendy Leisenring, Marie Bleakley, et al.
Blood|March 11, 2011
HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipientsDanielle M Zerr, Jesse R Fann, David Breiger, et al.
Blood|July 28, 2011
Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cellsCameron J Turtle, Jeff Delrow, Rochelle C Joslyn, et al.
The Lancet. Haematology|July 5, 2016
Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trialColleen Delaney, Filippo Milano, Laura Cicconi, et al.
Journal of Holistic Nursing : Official Journal of the American Holistic Nurses' Association|January 3, 2018
Trends in Contemporary Holistic Nursing Research: 2010-2015Colleen Delaney, Ruth G McCaffrey, Cynthia Barrere, et al.
Blood Advances|July 25, 2020
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter studyFilippo Milano, Jonathan A Gutman, H Joachim Deeg, et al.
Pageof 11